Ruff Shamim - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 26, 2023, Ruff Shamim's relationship to REATA PHARMACEUTICALS INC (RETA) is Director, and currently has 0 shares of Class A common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RETA insiders.

Data Source: SEC.
Ruff Shamim - Insider Non-Derivative Transactions of RETA Class A common stock
Ruff Shamim - Insider Non-Derivative Transactions at RETA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 27, 2023 Disposition -- (Class A common stock) 7359 0 0
Jul 29, 2023 Sell -- (Class A common stock) 8235 164.53 7359
Jul 29, 2023 M -- (Class A common stock) 1250 92.2 8609
Jul 29, 2023 M -- (Class A common stock) 6666 92.2 15275
Jul 29, 2023 M -- (Class A common stock) 319 92.2 15594
Jun 8, 2023 Acquisition -- (Class A common stock) 454 93.61 5677
Jun 8, 2023 Acquisition -- (Class A common stock) 1682 93.61 7359
Mar 11, 2023 Sell -- (Class A common stock) 5740 83.73 5223
Mar 11, 2023 M -- (Class A common stock) 199 27.32 5422
Mar 11, 2023 M -- (Class A common stock) 1326 34.76 6748
Mar 11, 2023 M -- (Class A common stock) 4215 34.76 10963